Have a feature idea you'd love to see implemented?
Let us know!
SNTI Senti Biosciences Inc.
Price (delayed)
$2.12
Market cap
$9.73M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$15.56
Enterprise value
$30.4M
Highlights
The debt has decreased by 7% YoY and by 2.9% from the previous quarter
The revenue has plunged by 100% from the previous quarter and by 100% YoY
SNTI's gross profit has dropped by 100% since the previous quarter and by 100% year-on-year
Key stats
What are the main financial stats of SNTI
Market
Valuations
Earnings
Shares outstanding
4.59M
Market cap
$9.73M
Enterprise value
$30.4M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.61
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$70.9M
EBITDA
-$65.03M
Free cash flow
-$34.78M
Per share
Balance sheet
Liquidity
EPS
-$15.56
Free cash flow per share
-$7.6
Book value per share
$3.49
Revenue per share
$0
TBVPS
$12.61
Total assets
$57.72M
Total liabilities
$41.73M
Debt
$34.71M
Equity
$15.99M
Working capital
$8.32M
Debt to equity
2.17
Current ratio
1.92
Quick ratio
1.56
Net debt/EBITDA
-0.32
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-77.4%
Return on equity
-154.8%
Return on invested capital
-76.6%
Return on capital employed
-145.7%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
SNTI stock price
How has the Senti Biosciences stock price performed over time
Intraday
0%
1 week
-9.01%
1 month
-6.19%
1 year
-42.23%
YTD
-67.88%
QTD
-6.19%
Financial performance
How have Senti Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$63.57M
Net income
-$70.9M
Gross margin
N/A
Net margin
N/A
The revenue has plunged by 100% from the previous quarter and by 100% YoY
SNTI's gross profit has dropped by 100% since the previous quarter and by 100% year-on-year
SNTI's operating income is up by 31% since the previous quarter and by 30% year-on-year
SNTI's net income is down by 24% from the previous quarter
Growth
What is Senti Biosciences's growth rate over time
Valuation
What is Senti Biosciences stock price valuation
P/E
N/A
P/B
0.61
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
SNTI's EPS is down by 23% since the previous quarter and by 10% year-on-year
Senti Biosciences's equity has shrunk by 81% YoY and by 64% QoQ
SNTI's P/B is 53% above its last 4 quarters average of 0.4
The revenue has plunged by 100% from the previous quarter and by 100% YoY
Efficiency
How efficient is Senti Biosciences business performance
The ROE has plunged by 130% YoY and by 70% from the previous quarter
The ROA has plunged by 69% YoY and by 50% from the previous quarter
The ROIC is down by 45% year-on-year and by 39% since the previous quarter
Dividends
What is SNTI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for SNTI.
Financial health
How did Senti Biosciences financials performed over time
The company's total assets is 38% higher than its total liabilities
SNTI's current ratio has dropped by 75% year-on-year and by 61% since the previous quarter
The quick ratio has dropped by 66% year-on-year and by 27% since the previous quarter
The debt is 117% more than the equity
SNTI's debt to equity has surged by 168% since the previous quarter
Senti Biosciences's equity has shrunk by 81% YoY and by 64% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.